Skip to main content
v2026.11,610 entries · CC-BY 4.0

Blocking in Experimental Design: RCBD Mechanics and When It Beats Simple Randomization

Blocking groups experimental units on a known nuisance source before treatments are assigned, then randomizes only within blocks — a design-stage control, not a post-hoc covariate adjustment. Covers RCBD mechanics, block sizing, the ANOVA change it obliges, and when it beats simple randomization for power.

Ask about Blocking in Experimental Design: RCBD Mechanics and When It Beats Simple Randomization

Answers are drawn from this guide and the rest of the CASRAI corpus, with a link to every source.

Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this

Written and maintained by CASRAI Editorial Board

Last updated

Blocking is a design-stage control, not a statistical fix applied after the data are in. When a nuisance source of variation is known in advance — a batch, a day, a site, a subject, a plot of land — blocking groups experimental units so that variation falls between blocks rather than inside them, before a single treatment is assigned. That is a different move from measuring a covariate and adjusting for it afterward in the model. This guide covers what blocking actually does, how the randomized complete block design (RCBD) restricts randomization to make it work, how it changes the analysis of variance, and when it genuinely improves power over simply randomizing treatments across all units.

Blocking Controls a Known Nuisance Variable — It Is Not a Covariate Adjustment

A nuisance variable is a source of variation in the response that isn’t of research interest but still affects the outcome — reagent lot, litter, day of testing, plot fertility, technician, instrument. If it goes unmanaged, it inflates the variance that treatment differences have to be detected against, which is exactly what confounding looks like when the nuisance source also happens to correlate with treatment assignment.

Blocking handles this at the design stage: experimental units are first sorted into blocks — groups that are as homogeneous as possible internally, on the nuisance factor specifically — and only then is treatment assigned within each block. The block itself is never randomized to; it is a grouping variable fixed by the known source of heterogeneity (four reagent lots, five testing days, six litters), and randomization operates only inside it.

This is a genuinely different move from the more familiar fix of measuring a covariate and adjusting for it statistically after the fact (as in ANCOVA). Covariate adjustment is a post-hoc correction applied to data that were collected under a design that didn’t control for the source in the first place — it can reduce residual variance and correct for imbalance that randomization didn’t fully erase, but it depends on the covariate being measured accurately, on the relationship between covariate and outcome being modeled correctly, and on there being no leftover confounding the model can’t see. Blocking removes the nuisance source from the comparison by construction: because every treatment is compared to every other treatment within the same block, block-to-block variation cancels out of the treatment comparison regardless of how well any statistical model happens to capture it. The trade-off is that blocking has to be planned before data collection — it isn’t available as a rescue once the study has already run without it.

The Randomized Complete Block Design (RCBD): How It Works

The randomized complete block design is the standard implementation of blocking, and it follows R. A. Fisher’s original design-of-experiments logic (formalized in agricultural field trials, where “block” meant a plot of land with locally uniform soil conditions, and generalized since to any field). Three requirements define it:

  • Blocks are formed on the nuisance factor. Units within a block are chosen or grouped specifically because they are similar on the variable being controlled for — same reagent lot, same day, same litter, same site — and different blocks are expected to differ on it.
  • Every treatment appears in every block — that’s what makes it “complete.” If an experiment has four treatments, each block contains all four; a design where some blocks are missing a treatment is an incomplete block design instead (see block sizing, below), which needs a different analysis.
  • Randomization happens within blocks, not across the whole experiment. Inside each block, which unit gets which treatment is assigned at random. Across blocks, nothing is randomized — block membership is fixed by the known nuisance source. This is a restriction on randomization relative to a completely randomized design (CRD), where treatment assignment is randomized across every unit in the study with no grouping at all.

A worked illustration, using round numbers rather than a real dataset: an assay compares three treatment conditions, and the reagent is known to vary meaningfully between the four lots available. Complete randomization would assign all 12 runs to treatments at random and let lot-to-lot variation land wherever it happened to land — potentially concentrating one treatment in one lot by chance. An RCBD instead treats each of the four lots as a block, runs all three treatments once within each lot, and randomizes only which run-position gets which treatment inside that lot. Lot-to-lot differences in the reagent no longer contaminate the treatment comparison, because every treatment was tested against every lot equally.

Choosing Block Size: Why Blocks Have to Be Complete

A block has to be large enough to hold at least one experimental unit per treatment — block size equal to the number of treatments is the minimum for a single-replicate RCBD, and a multiple of that number if you want more than one observation per treatment per block. This is a real constraint, not a formality: a litter with three pups can’t host a four-treatment RCBD as a complete block. Two options exist when natural block size falls short of the treatment count:

  • Reduce block size and use an incomplete block design (e.g., a balanced incomplete block design, BIBD), where each block holds only a subset of treatments and the analysis has to account for which treatments were and weren’t compared within each block. This is a materially more complex analysis than the RCBD’s, and worth it only when complete blocks genuinely aren’t available.
  • Use a larger or differently defined blocking unit that can accommodate every treatment — combining smaller natural groupings into a bigger block, if that’s defensible on the nuisance factor itself.

A second, more common sizing decision is how many nuisance dimensions to block on at once. Blocking on a single factor (one blocking variable) is standard RCBD. When two independent nuisance factors both need controlling — row and column effects on a plate, for instance — a Latin square design blocks on both simultaneously with the same restricted-randomization logic, at the cost of requiring the number of blocks to match the number of treatments in both directions.

How Blocking Changes the Analysis of Variance

A completely randomized design with one treatment factor is analyzed with a one-way ANOVA: total variation splits into a treatment sum of squares and an error sum of squares, and the F-test compares treatment variation against whatever’s left in error. Adding blocking changes that partition. An RCBD is analyzed as a two-way ANOVA with treatment and block as the two factors, ordinarily without an interaction term (a single observation per treatment per block gives no way to estimate one) — see CASRAI’s two-way ANOVA and running ANOVA in R guides for the mechanics of fitting that model. Total variation now splits three ways: treatment, block, and error.

The reason this matters for power: whatever sum of squares is attributable to blocks is subtracted out of the error term rather than left inside it. If the block factor genuinely explains real variation in the outcome, the mean square error in the RCBD analysis is smaller than the mean square error a CRD analysis of the same data would have produced — and a smaller error term means a larger F-statistic and more power to detect a real treatment effect, for the same sample size. Blocking costs a few degrees of freedom (one per block minus one, taken from what would otherwise be error degrees of freedom in a CRD), but if the block effect is real, the variance it removes from the error term more than pays for the degrees of freedom it consumes.

When Blocking Beats Simple Randomization for Power — and When It Doesn’t

The condition for blocking to help is specific, not automatic: the blocking factor has to actually explain a meaningful share of the variance in the response. When it does, an RCBD is more powerful than a CRD run on the same units and the same total sample size, because the error term shrinks by more than the lost degrees of freedom cost. This is the standard justification for blocking on batch, site, day, litter, or subject whenever that factor is known ahead of time to move the outcome — multi-site studies blocking on site, lab assays blocking on reagent lot or run date, and within-subject designs blocking on subject are all the same underlying logic.

The reverse also holds, and it is the reason blocking isn’t a default to reach for on every factor available. If the chosen blocking variable turns out not to meaningfully affect the response, the RCBD analysis still spends degrees of freedom removing it from the error term for no real variance reduction in return — the design ends up less efficient than a CRD would have been with those degrees of freedom left in error, for no offsetting benefit. Relative efficiency — comparing the estimated error variance an RCBD achieved against what a CRD on the same units would have produced — is the formal way to check this after the fact; the practical version is to block only on a factor there’s real prior reason to expect matters, not on every available grouping variable.

Blocking is also distinct from randomization itself, not a replacement for it: an RCBD still relies on randomization to assign treatments within each block, which is what protects against unknown and unmeasured confounders the way randomization always does. Blocking adds control over one known nuisance source on top of that; it doesn’t substitute for randomizing the rest.

Frequently Asked Questions

What is blocking in experimental design?

Blocking is grouping experimental units into blocks that are internally homogeneous on a known nuisance variable, before treatments are assigned, so that block-to-block variation is removed from the treatment comparison rather than left in the error term. Treatments are then randomized only within each block.

What’s the difference between blocking and randomization?

Randomization assigns treatments to units by chance to protect against unknown and unmeasured confounders. Blocking is a restriction placed on that randomization for one specific, known nuisance source: units are first grouped by that source, and randomization happens only within each group. An RCBD uses both — blocking for the known factor, randomization within blocks for everything else.

What’s a real example of a randomized complete block design?

A multi-site trial that runs every treatment arm at every site, randomizing which participants at each site get which treatment, is an RCBD with site as the block. A lab experiment that runs every treatment condition once per reagent lot, randomizing run order within each lot, is the same design applied to a bench-science nuisance factor.

When should blocking be skipped in favor of simple randomization?

When there’s no known nuisance factor worth controlling for, or when a candidate blocking factor isn’t expected to meaningfully affect the outcome. Blocking on a factor that doesn’t actually explain variance still costs degrees of freedom in the analysis without reducing the error term enough to pay for them, making the design less efficient than a straightforward CRD.

Is blocking the same as stratification?

They’re close relatives built on the same logic — grouping units on a known factor before assignment — but stratified randomization is the term generally used in survey sampling and clinical-trial allocation, while blocking and the RCBD are the classical experimental-design and ANOVA framing of the same idea. The mechanics and the justification (remove a known nuisance source from the comparison) are the same.

Related CASRAI Resources

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →

Regulatory Radar

Stop finding out after the fact

$29/month, cancel anytime. Daily digest updates from our analysis, a dashboard holding the same items, and a cited assistant for everything they raise.

  • Federal Register, Federal Register+, Grants.gov, Regulations.gov, NSF News, UKRI, plus CASRAI’s own published content.
  • 44,322 indexed passages, and every answer cites the ones it drew on.